OCELLOS by TrakCel helps patients receive the right therapy at the right time.
Cardiff, Wales, February 25th, 2021– TrakCel today announced it has launched OCELLOS by TrakCel on Salesforce AppExchange, empowering customers with an end-to-end solution that connects Healthcare Providers, Supply Chain, Manufacturing, IT, Quality, Clinical Trial and Commercial teams all on one platform.
Integrated directly with Salesforce, OCELLOS is currently available on AppExchange here.
OCELLOS by TrakCel
Going beyond Chain of Identity (COI) and Chain of Custody (COC), TrakCel has built a solution-architecture on Salesforce that offers interoperable Base Modules that are ready for configuration ‘out-of-the-box’. These will serve most of the needs of the cell and gene therapy value chain from development through commercialization. TrakCel’s experience in managing a broad set of live implementations (CAR-T, MIL, TIL, PCV, CRISPR) in allogeneic and autologous settings has led to the development of the initial set of Base Modules. The Module Library, already the largest in the industry, is growing regularly based on community demand, allowing TrakCel to further add new capabilities to OCELLOS.
TrakCel has partnered with Mulesoft (TM) to develop an Integration Hub that centralizes integrations with service providers and utilities into one, API (Application Programming Interface)-sharing module. The number of live integrations is growing with service providers, information systems and other utilities. The Integration Hub allows for better patient service and business decision making flexibility, reporting and analysis.
The Module Library and Integration Hub make OCELLOS faster, easier and more cost-effective to implement and use. The configurability, usability and scalability of the solution enables the industry to improve visibility into value chains and to provide the flexibility the rapidly changing environment requires. TrakCel can offer OCELLOS as a ready-made, end-to-end solution to manage the value chain of advanced therapies.
TrakCel will provide improved accessibility and efficiencies to its client base, with Salesforce already heavily adopted by cell and gene therapy developers and industry partners as part of their technology stack.
Comments on the News
- “The General Availability of OCELLOS by TrakCel marks a step into the future for cell orchestration solutions. We now have a platform that is built specifically to allow scalability and flexibility. As our Module Library and Integrations grow, our clients will enjoy faster and more cost-effective start-ups and all of it will be easier to use and understand,” says Fiona Withey, CEO at TrakCel. “I think our clients will be very impressed with OCELLOS by TrakCel’s usability and I encourage service providers in the CGT space to contact us to schedule integrations so that your services can be immediately available to our clients.”
- “OCELLOS is a welcome addition to AppExchange, as they power digital transformation for customers by streamlining the delivery of advanced therapies” said Woodson Martin, GM of Salesforce AppExchange. “AppExchange is constantly evolving to connect customers with the right apps and experts for their business needs.”
ENDS
About Salesforce AppExchange
Salesforce AppExchange, the world’s leading enterprise cloud marketplace, empowers companies, developers and entrepreneurs to build, market and grow in entirely new ways. With more than 6,000 listings, 9 million customer installs and 117,000 peer reviews, AppExchange connects customers of all sizes and across industries to ready-to-install or customizable apps and Salesforce-certified consultants to solve any business challenge.
Salesforce, AppExchange and others are among the trademarks of salesforce.com, inc.
About TrakCel
TrakCel is a leading innovator of integrated technologies specifically created in 2012 to manage the international autologous and allogeneic cell, gene and immunotherapy supply chain. TrakCel’s software platform has been developed in collaboration with, and increasingly adopted by leading companies in the cell, gene and immunotherapy industries. TrakCel’s solutions deliver real-time control over the entire therapeutic value supply chain, from sample collection through manufacturing to treatment delivery. The TrakCel platform can accelerate global scale up and scale out of cell and gene therapy products, increasing efficiency and decreasing complexity, while maintaining treatment collection to administration compliance and traceability. TrakCel is headquartered in Cardiff, Wales, UK with US offices in California and New Jersey.
To learn more about how OCELLOS can help with your cell and gene tracking challenges review our product features or request a demo from on of our consultants.
Article by TrakCel Marketing Team - 25 Feb 2021
